Abstract
Morbidity and mortality from coronavirus disease 2019 (COVID-19) is higher among people with diabetes mellitus (DM), hypertension, and cardiovascular disease (CVD). Statins are used in the majority of people with DM and CVD. This mini-review discusses the current understanding of benefit-risk ratio of use of statins in COVID-19. We searched PubMed database using specific keywords related to our aims till June 12, 2020. Full text of relevant articles published in English language were retrieved and reviewed. Statins, with their immunomodulatory, anti-inflammatory, anti-thrombotic, and anti-oxidant properties, have the potential to reduce severity of lung injury in, and mortality from, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV2) infections. Statin-induced upregulation of angiotensin-converting enzyme-2 (ACE2) has the potential to reduce lung injury from excess angiotensin II. By disrupting lipid rafts, statins have the potential to reduce viral entry into cells. However, benefit-risk ratio of its complex interaction with MYD88 gene expression on outcomes in COVID-19, and the putative role of low serum LDL cholesterol in increasing severity of SARS-CoV2 infection need further clarification. People with COVID-19, wh...Continue Reading
Citations
Nov 1, 2020·Scientific Reports·Chansik AnSeong Woo Kim
Dec 18, 2020·Frontiers in Medicine·Yongzhen FanZhibing Lu
Nov 5, 2020·Biomedicines·Danah MuhannaOuliana Ziouzenkova
Feb 2, 2021·Translational Medicine Communications·Payam PeymaniSaeid Ghavami
Jan 15, 2021·Viruses·Jerome E Tanner, Caroline Alfieri
Feb 23, 2021·International Reviews of Immunology·Yifan QueGuogang Xu
Dec 7, 2020·Diabetes & Metabolic Syndrome·Tie Zhao, Liang Peng
Dec 29, 2020·Diabetes & Metabolism·André J Scheen
Feb 23, 2021·Frontiers in Cell and Developmental Biology·Maurizio SoriceVincenzo Mattei
Feb 23, 2021·Frontiers in Medicine·Ivana MarićDavid K Stevenson
Feb 24, 2021·The FEBS Journal·Eugene MerzonEli Magen
Apr 30, 2021·Progress in Lipid Research·Maria Chiara ProtoMaurizio Bifulco
May 1, 2021·Journal of Clinical Medicine·Andreea-Luciana BuicuTheodora Benedek
May 7, 2021·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuji IkariShingo Matsumoto
Jun 8, 2021·Annals of Medicine·Kuan-Sheng WuPei-Ling Tang
Jun 22, 2021·Biochimie·Stéphane OrlowskiEric Bruckert
Jul 3, 2021·Life·Justyna Olszewska-ParasiewiczDariusz A Kosior
Jul 13, 2021·BioMed Research International·Alireza DavoudiMarzieh Rabiee
Oct 4, 2019·Archives of Medical Science : AMS·Ercan YuvancErdal Yilmaz
Jul 11, 2021·Pharmacoepidemiology and Drug Safety·Salka EnnersMartin Schulz
Aug 7, 2021·Journal of Cardiovascular Development and Disease·Nasim KiaieAmirhossein Sahebkar
Aug 20, 2021·Frontiers in Immunology·Jiao LiuDechang Chen
Sep 1, 2021·Expert Opinion on Pharmacotherapy·Maryam KhanAmer Harky
Sep 11, 2021·Frontiers in Immunology·Miao ZouManman Su
Oct 28, 2021·Zentralblatt für Chirurgie·Yvonne GoßlauAlexander Hyhlik-Dürr
Nov 2, 2021·IScience·Ali KishkThomas Sauter